SUMMARY Ambulatory oesophageal pH, oesophageal manometry and fasting serum gastrin concentrations were carried out on 28 patients with reflux oesophagitis, before and during treatment with ranitidine 300 mg bd. Fourteen patients healed endoscopically at six weeks (group A) and 14 had residual oesophagitis (group B). Group A were characterised by a lower serum gastrin concentration before treatment (4.52 pmol/l; 2-4-10: mean and range) than group B (11
H2 antagonists are widely used in the treatment of gastroesophageal acid reflux, but as many as 50% of patients fail to respond to conventional or high dose regimes such as cimetidine 800 g bd,' either symptomatically or with endoscopic healing of oesophagitis. The reason for this high failure rate is unknown. H2 antagonists reduce acid secretion, and therefore the potency and volume of refluxed material, but other properties of these drugs may also be important. H2 antagonists cause an increase in gastrin concentrations which may increase the tone in the lower oesophageal sphincter in oesophagitis' and affect oesophageal motility. Abnormal motility with poor lower oesophageal sphincter function is common in oesophagitis, and persistence of these abnormalities may decrease the value of reduced gastric acid secretion in oesophagitis. We Abnormal oesophageal motility was common, affecting 26 of the 28 patients with an average frequency of abnormal peristaltic waves 6 5/20 swallows before treatment, 6-3/20 swallows after treatment. This was more marked in group B (7-2/20 swallows) than group A (5-9/20 sw(allows), but not significantly so. Lower oesophageal sphincter pressure was not affected by treatment (mean 27-0 mmHg pretreatment, 27-7 mmHg post-treatment) and was similar in both groups (group A 27-8 mmHg, group B 26-8 mmHg).
Fasting gastrin concentrations increased significantly during treatment (p<0.01) (Fig. 1) . In addition, group A had a significantly lower pretreatment gastrin level than group B (4-52 pmol/l aigainst 11-1 pmol/l, p<0(05). There was evidence of abnormal acid reflux in 24 of the 28 patients.4 Acid reflux characteristics are shown in Table 2 and Figure 2 before aind after treltment. In group A there was a significant reduction in both the frequency and duration of acid reflux which did not occur in group B. There was relatively little nocturnal reflux, mean time below pH4 was 3.4%io (0-0-15.0) between the hours of 12 midnight and 8X00 am. There wias a close correlation between reflux data in the 16 patients undergoing 24 hour pH studies for the three hour postprandial period compared with the 24 hours.' The frequency/duration index" for three hours correlated with frequency duration index for 24 hours (r=089, p<0001). phagitis, and was often not severe; 10 patients (five in each group) recorded values of less than 4% of time below pH4, but six of these had two or more episodes of reflux longer than five minutes. Ranitidine reliably reduces gastric acid secretion,' and in duodenal ulcer this is associated with healing in approximately 90% of cases within six weeks. The 50% of patients who failed to heal in this study had acid reflux of similar severity before and during treatment, suggesting that their postprandial acid secretion is not adequately suppressed by ranitidine, or that other factors are more important in this group. We were unable to identify any significant clinical associations with healing. The patients who healed were more likely to be women, to be slightly younger, less likely to smoke, and have slightly less severe oesophagitis, with a shorter duration of symptoms, that those who failed to heal. These associations were weak and did not approach statistical significance. Frequency and severity of symptoms were similar in both groups. There was no H1, antagonists in the treatment ofreflux oesophalgitis: ca(n plilysiologic'al stluci(es' predic(t the respoinse? 949 evidence that oesophageal dysmotility was more common or severe in non-healers.
Abnormal motility in the body of the oesophagus is common in oesophagitis,"' and occurred in most of our patients, with an average of 30% abnormal peristaltic waves. It is still not clear whether this is the cause or an effect of acid reflux, although recent studies" have shown that abnormal oesophageal motility improves after fundoplication, suggesting that dysmotility is secondary to reflux. In this study, the presence of abnormal peristalsis did not inhibit the response to ranitidine, but healing was not associated with an improvement in motility. This suggests that disturbed oesophageal motility is not of primary importance in healing of oesophagitis, although it may be an important feature in the development of oesophagitis. Furthermore, motility has been measured in the supine, fasting patient, often when symptoms have not been severe, and other methods of assessing motility may yet demonstrate important primary abnormalities. The lower oesophageal sphincter pressure was within the normal range for our laboratory and was not altered by treatment with ranitidine, although there was a marked increase in gastrin concentrations said to be associated with an increase in tone of the lower oesophageal sphincter.'2 In group A, the fasting pretreatment gastrin concentrations were significantly lower than in group B. It may be that lower gastrin concentrations in responders reflect a high basal acid output, and so identifies those patients who are most likely to respond to inhibitors of gastric acid secretion. The gastrin level was the only factor in the pretreatment assessment that was associated with a satisfactory response to ranitidine, but it is not suggested that this is a useful diagnostic test to identify potential responders, though low levels may reflect the underlying pathophysiology. Ambulatory pH recording did not identify patients likely to respond and cannot be recommended as a tool for patient selection for this form of therapy.
Although group B still had residual oesophagitis after six weeks treatment, 12 had improved symptomatically and no additional treatment was required. Two patients underwent antireflux surgery (follow up nine months).
It appears that the beneficial effects of ranitidine in oesophagitis can be entirely attributed to reduction in acid secretion in those who respond, in whom there is a reduction in the frequency and severity of acid reflux. Pattients who fail to respond do not have a reduction in severity or frequency of reflux, for reasons that are not clear. 
